Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1996-2001
Published online before print September 18, 2003, doi: 10.1161/01.ATV.0000096208.80992.63
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
23/11/1996    most recent
01.ATV.0000096208.80992.63v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamada, M.
Right arrow Articles by Iwao, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamada, M.
Right arrow Articles by Iwao, H.
Related Collections
Right arrow Health policy and outcome research
Right arrow Coagulation inhibitors
Right arrow Coumarins
Right arrow CV surgery: other
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1996.)
© 2003 American Heart Association, Inc.


Vascular Biology

Molecular Mechanism and Role of Endothelial Monocyte Chemoattractant Protein-1 Induction by Vascular Endothelial Growth Factor

Motoko Yamada; Shokei Kim; Kensuke Egashira; Motohiro Takeya; Tomohiro Ikeda; Osamu Mimura; Hiroshi Iwao

From the Department of Pharmacology (M.Y., S.K., H.I.), Osaka City University Medical School, Osaka; the Department of Ophthalmology (M.Y., T.I., O.M.), Hyogo College of Medicine, Hyogo; the Department of Cardiovascular Medicine (K.E.), Graduate School of Medical Science, Kyusyu University, Fukuoka; and the Second Department of Pathology (M.T.), Kumamoto University School of Medicine, Kumamoto, Japan.

Correspondence to Shokei Kim, MD, Department of Pharmacology, Osaka City University Medical School, 1-4-3 Asahimachi, Abeno, Osaka, 545-8585, Japan. E-mail kims{at}med.osaka-cu.ac.jp

Objective— We investigated the role of monocyte chemoattractant protein-1 (MCP-1) in vascular endothelial growth factor (VEGF)–induced angiogenesis and vascular permeability and the underlying molecular mechanism of VEGF-induced endothelial MCP-1 expression in vitro and in vivo.

Methods and Results— We used an anti–MCP-1 neutralizing antibody for specific inhibition of MCP-1. VEGF increased tubule formation in the angiogenesis assay and vascular permeability in the Miles assay, and these effects were markedly inhibited by anti–MCP-1 antibody. Using a luciferase MCP-1 promoter-gene assay, we found that the activator protein-1 (AP-1) binding site of the MCP-1 promoter region contributes to the increase in MCP-1 promoter activity by VEGF. To specifically inhibit AP-1, we used recombinant adenovirus containing a dominant-negative c-Jun (Ad-DN-c-Jun). Ad-DN-c-Jun inhibited VEGF-induced endothelial MCP-1 mRNA expression and promoter activity in vitro. In vivo gene transfer of DN-c-Jun into rat carotid artery, with the hemagglutinating virus of the Japan liposome method, significantly blocked VEGF-induced MCP-1 and macrophage/monocyte (ED1) expression in endothelium.

Conclusions— These results reveal that endothelial MCP-1 induced by VEGF seems to participate in angiogenesis, vascular leakage, or arteriosclerosis. AP-1 plays a critical role in the molecular mechanism underlying induction of MCP-1 by VEGF.


Key Words: angiogenesis • vascular permeability • gene transfer • activator protein-1 • dominant-negative mutant




This article has been cited by other articles:


Home page
Clin. Microbiol. Rev.Home page
B. E. E. Martina, P. Koraka, and A. D. M. E. Osterhaus
Dengue Virus Pathogenesis: an Integrated View
Clin. Microbiol. Rev., October 1, 2009; 22(4): 564 - 581.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J.-i. Koga, T. Matoba, K. Egashira, M. Kubo, M. Miyagawa, E. Iwata, K. Sueishi, M. Shibuya, and K. Sunagawa
Soluble Flt-1 Gene Transfer Ameliorates Neointima Formation After Wire Injury in flt-1 Tyrosine Kinase-Deficient Mice
Arterioscler Thromb Vasc Biol, April 1, 2009; 29(4): 458 - 464.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. H. Lee, J. H. Woo, S. U. Woo, K. S. Kim, S. M. Park, E.-h. Joe, and I. Jou
The 15-Deoxy-{Delta}12,14-Prostaglandin J2 Suppresses Monocyte Chemoattractant Protein-1 Expression in IFN-{gamma}-Stimulated Astrocytes through Induction of MAPK Phosphatase-1
J. Immunol., December 15, 2008; 181(12): 8642 - 8649.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
B. J. Capoccia, A. D. Gregory, and D. C. Link
Recruitment of the inflammatory subset of monocytes to sites of ischemia induces angiogenesis in a monocyte chemoattractant protein-1-dependent fashion
J. Leukoc. Biol., September 1, 2008; 84(3): 760 - 768.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. C.A. Stene, R. Frikke-Schmidt, B. G. Nordestgaard, P. Grande, P. Schnohr, and A. Tybjaerg-Hansen
Functional Promoter Variant in Zinc Finger Protein 202 Predicts Severe Atherosclerosis and Ischemic Heart Disease
J. Am. Coll. Cardiol., July 29, 2008; 52(5): 369 - 377.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Wolter, A. Doerrie, A. Weber, H. Schneider, E. Hoffmann, J. von der Ohe, L. Bakiri, E. F. Wagner, K. Resch, and M. Kracht
c-Jun Controls Histone Modifications, NF-{kappa}B Recruitment, and RNA Polymerase II Function To Activate the ccl2 Gene
Mol. Cell. Biol., July 1, 2008; 28(13): 4407 - 4423.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Egashira, K. Nakano, K. Ohtani, K. Funakoshi, G. Zhao, Y. Ihara, J.-i. Koga, S. Kimura, R. Tominaga, and K. Sunagawa
Local Delivery of Anti-Monocyte Chemoattractant Protein-1 by Gene-Eluting Stents Attenuates In-Stent Stenosis in Rabbits and Monkeys
Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2563 - 2568.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
O. Ochoa, D. Sun, S. M. Reyes-Reyna, L. L. Waite, J. E. Michalek, L. M. McManus, and P. K. Shireman
Delayed angiogenesis and VEGF production in CCR2 / mice during impaired skeletal muscle regeneration
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2007; 293(2): R651 - R661.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. E. Pellett
Totally tubular: virally induced endothelial tube formation
Blood, April 1, 2007; 109(7): 2669 - 2670.
[Full Text] [PDF]


Home page
BloodHome page
J. Ma, Q. Wang, T. Fei, J.-D. J. Han, and Y.-G. Chen
MCP-1 mediates TGF-{beta}-induced angiogenesis by stimulating vascular smooth muscle cell migration
Blood, February 1, 2007; 109(3): 987 - 994.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
Y.-R. Lee, M.-T. Liu, H.-Y. Lei, C.-C. Liu, J.-M. Wu, Y.-C. Tung, Y.-S. Lin, T.-M. Yeh, S.-H. Chen, and H.-S. Liu
MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells
J. Gen. Virol., December 1, 2006; 87(12): 3623 - 3630.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. Yamaji-Kegan, Q. Su, D. J. Angelini, H. C. Champion, and R. A. Johns
Hypoxia-induced mitogenic factor has proangiogenic and proinflammatory effects in the lung via VEGF and VEGF receptor-2
Am J Physiol Lung Cell Mol Physiol, December 1, 2006; 291(6): L1159 - L1168.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Fujii, Y. Yonemitsu, M. Onimaru, M. Tanii, T. Nakano, K. Egashira, T. Takehara, M. Inoue, M. Hasegawa, H. Kuwano, et al.
Nonendothelial Mesenchymal Cell-Derived MCP-1 Is Required for FGF-2-Mediated Therapeutic Neovascularization: Critical Role of the Inflammatory/Arteriogenic Pathway
Arterioscler Thromb Vasc Biol, November 1, 2006; 26(11): 2483 - 2489.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W. Qi, X. Chen, J. Holian, E. Mreich, S. Twigg, R. E. Gilbert, and C. A. Pollock
Transforming growth factor-beta1 differentially mediates fibronectin and inflammatory cytokine expression in kidney tubular cells
Am J Physiol Renal Physiol, November 1, 2006; 291(5): F1070 - F1077.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
D. K. Meyerholz, B. Grubor, T. Lazic, J. M. Gallup, M. M. A. de Macedo, P. B. McCray, and M. R. Ackermann
Monocytic/Macrophagic pneumonitis after intrabronchial deposition of vascular endothelial growth factor in neonatal lambs.
Vet. Pathol., September 1, 2006; 43(5): 689 - 694.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Ishikawa, T. Vowinkel, K. Y. Stokes, T. V. Arumugam, G. Yilmaz, A. Nanda, and D. N. Granger
CD40/CD40 Ligand Signaling in Mouse Cerebral Microvasculature After Focal Ischemia/Reperfusion
Circulation, April 5, 2005; 111(13): 1690 - 1696.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. H. Hong, J. Ryu, and K. H. Han
Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A
Blood, February 15, 2005; 105(4): 1405 - 1407.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Q. Zhao, K. Egashira, K.-i. Hiasa, M. Ishibashi, S. Inoue, K. Ohtani, C. Tan, M. Shibuya, A. Takeshita, and K. Sunagawa
Essential Role of Vascular Endothelial Growth Factor and Flt-1 Signals in Neointimal Formation After Periadventitial Injury
Arterioscler Thromb Vasc Biol, December 1, 2004; 24(12): 2284 - 2289.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Ohtani, K. Egashira, K.-i. Hiasa, Q. Zhao, S. Kitamoto, M. Ishibashi, M. Usui, S. Inoue, Y. Yonemitsu, K. Sueishi, et al.
Blockade of Vascular Endothelial Growth Factor Suppresses Experimental Restenosis After Intraluminal Injury by Inhibiting Recruitment of Monocyte Lineage Cells
Circulation, October 19, 2004; 110(16): 2444 - 2452.
[Abstract] [Full Text] [PDF]